Health 5-Year Follow-Up: Durable Remissions with Dual CD19/CD20 CAR-T in Lymphoma by Grace Chen April 1, 2026 written by Grace Chen April 1, 2026 63 Related readingSIRI Marker Identified as Top Predictor for Stroke Recurrence RiskProstate Surgery Incontinence: The Hidden Emotional and Physical Toll on Men Related 0 comments 0 FacebookTwitterPinterestEmail Grace Chen Board-certified physician and medical writer. Translates research into practical health advice and public-health coverage. previous post Devonport Teen Assault: Mob Attack Leaves Family Terrified next post Dodgers Start 2026 Season 2-0 Amid Fan Fights & Protestors You may also like SIRI Marker Identified as Top Predictor for Stroke... July 24, 2026 Prostate Surgery Incontinence: The Hidden Emotional and Physical... July 24, 2026 Oxford University Begins Human Trials for First Bundibugyo... July 24, 2026 GammaTile Brain Implant Doubles Survival and Cuts Tumor... July 24, 2026 Semaglutide and Tirzepatide Linked to Fewer Alcohol-Related Hospital... July 24, 2026 Ozempic and Mounjaro Linked to Modest Increase in... July 24, 2026 Remote Heart Monitoring Helps Improve Rural Heart Failure... July 24, 2026 Graph Alignment Breakthrough: Dual-Graph Topology Alignment for Single-Cell... July 24, 2026 NHS England offers fampridine to improve walking for... July 23, 2026 Fampridine approved for NHS, 120,000 MS patients to... July 23, 2026 Leave a Comment Cancel Reply Notify me of follow-up comments by email. Notify me of new posts by email. Δ
